chlorpromazine has been researched along with Hyperprolactinemia in 7 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperprolactinemia is a common side effect of antipsychotic drugs that requires further investigation." | 5.42 | Chlorpromazine-Induced Hyperprolactinemia on Rat's Uterus. ( Ahmadi, A; Movahed, E; Sadrkhanlou, R; Zamani, Z; Zare, S, 2015) |
| "Hyperprolactinemia is a common side effect of antipsychotic drugs that requires further investigation." | 1.42 | Chlorpromazine-Induced Hyperprolactinemia on Rat's Uterus. ( Ahmadi, A; Movahed, E; Sadrkhanlou, R; Zamani, Z; Zare, S, 2015) |
| "The 39% recurrence rate of hyperprolactinemia and persistent abnormalities in pituitary-hypothalamic regulation of PRL secretion after transsphenoidal surgery raise important questions about the choice of primary therapy for patients with PRL-secreting tumors." | 1.27 | Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors. ( Chapler, FK; Schlechte, JA; Sherman, BM; VanGilder, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lange, JH | 1 |
| Reinders, JH | 1 |
| Tolboom, JT | 1 |
| Glennon, JC | 1 |
| Coolen, HK | 1 |
| Kruse, CG | 1 |
| Yakubu, MT | 1 |
| Fayemo, HT | 1 |
| Zamani, Z | 1 |
| Zare, S | 1 |
| Sadrkhanlou, R | 1 |
| Ahmadi, A | 1 |
| Movahed, E | 1 |
| Kunimatsu, T | 1 |
| Kimura, J | 1 |
| Funabashi, H | 1 |
| Inoue, T | 1 |
| Seki, T | 1 |
| Meaney, AM | 1 |
| Smith, S | 1 |
| Howes, OD | 1 |
| O'Brien, M | 1 |
| Murray, RM | 1 |
| O'Keane, V | 1 |
| Azuma, K | 1 |
| Irahara, M | 1 |
| Aono, T | 1 |
| Schlechte, JA | 1 |
| Sherman, BM | 1 |
| Chapler, FK | 1 |
| VanGilder, J | 1 |
1 review available for chlorpromazine and Hyperprolactinemia
| Article | Year |
|---|---|
[Metoclopramide, sulpiride, and chlorpromazine loading test].
Topics: Chlorpromazine; Humans; Hyperprolactinemia; Metoclopramide; Pituitary Function Tests; Pituitary Glan | 1997 |
6 other studies available for chlorpromazine and Hyperprolactinemia
| Article | Year |
|---|---|
Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzoxazines; Biogenic Monoamines; Humans; Hyperprolac | 2007 |
Anti-hyperprolactinemic activities of aqueous extract of Uvaria chamae (P. Beauv) roots and associated biochemical changes in chlorpromazine-induced hyperprolactinemic female Wistar rats.
Topics: Animals; Chlorpromazine; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia | 2021 |
Chlorpromazine-Induced Hyperprolactinemia on Rat's Uterus.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Estradiol; Female; Follicle Stimulating Hormone; Gala | 2015 |
The antipsychotics haloperidol and chlorpromazine increase bone metabolism and induce osteopenia in female rats.
Topics: Amino Acids; Animals; Antipsychotic Agents; Bone and Bones; Bone Density; Bone Diseases, Metabolic; | 2010 |
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia.
Topics: Adult; Age Factors; Antipsychotic Agents; Bone Density; Chlorpromazine; Dopamine Antagonists; Female | 2004 |
Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
Topics: Adenoma; Adolescent; Adult; Chlorpromazine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; I | 1986 |